Used in immunological research to quantify levels of terminal complement complex (TCC) C5b-9 in biological samples, this ELISA kit enables assessment of complement system activation. It is particularly valuable in studies related to inflammation, autoimmune diseases, and tissue damage, where uncontrolled complement activation plays a key role. Researchers use it to monitor disease progression or evaluate therapeutic interventions targeting the complement pathway in mouse models. The assay provides a sensitive and specific measurement of soluble C5b-9, allowing for early detection of membrane attack complex formation in serum, plasma, or other fluids.